牛熊異動 | 目標價上調,港交牛證大漲150%!
香港交易所今日高開逾2%,最高見529港元,截止發稿,香港交易所漲3.13%,報527港元,港交瑞銀一八牛T漲超150%。
【通過日內融買入1手香港交易所,僅需佔用本金2600港元】
摩根士丹利表示,港股通年迄今淨買入已達400億美元,今年剩餘時間最高可能還有900億美元的淨買入,勢頭維持強勁但今年後半段或趨平緩;上調香港交易所目標價40%,中國內地流動性依然是港交所最大的長期推動力。分析師Richard Xu等人在另一份報告中表示, 將香港交易所2021-2022年每股收益預測分別上調13%和10%,因日均成交 假設上調;目標價由430港元上調至600港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.